Getinge AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
883 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
October 31, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 21, 2017 | Bank of Montreal | 0.83% | still open |
| March 20, 2017 | Bank of Montreal | 0.83% | still open |
| March 20, 2017 | GLG Partners LP | 0.63% | still open |
| March 19, 2017 | GLG Partners LP | 0.63% | still open |
| March 16, 2017 | GLG Partners LP | 0.59% | still open |
| March 15, 2017 | GLG Partners LP | 0.62% | still open |
| March 14, 2017 | GLG Partners LP | 0.62% | still open |
| March 13, 2017 | BlackRock Investment Management (UK) Limited | 0.99% | still open |
| March 12, 2017 | BlackRock Investment Management (UK) Limited | 0.99% | still open |
| March 8, 2017 | GLG Partners LP | 0.59% | still open |
| March 8, 2017 | Marshall Wace LLP | 0.50% | still open |
| March 7, 2017 | GLG Partners LP | 0.59% | still open |
| March 7, 2017 | Marshall Wace LLP | 0.50% | still open |
| March 3, 2017 | BlackRock Investment Management (UK) Limited | 1.00% | still open |
| March 2, 2017 | BlackRock Investment Management (UK) Limited | 1.00% | still open |
| March 2, 2017 | GLG Partners LP | 0.60% | still open |
| March 1, 2017 | GLG Partners LP | 0.60% | still open |
| February 27, 2017 | Citadel Europe LLP | 0.59% | still open |
| February 27, 2017 | Marshall Wace LLP | 0.51% | still open |
| February 26, 2017 | Citadel Europe LLP | 0.59% | still open |
| February 26, 2017 | Marshall Wace LLP | 0.51% | still open |
| February 14, 2017 | GLG Partners LP | 0.59% | still open |
| February 13, 2017 | BlackRock Investment Management (UK) Limited | 0.90% | still open |
| February 13, 2017 | GLG Partners LP | 0.59% | still open |
| February 12, 2017 | BlackRock Investment Management (UK) Limited | 0.90% | still open |
| February 10, 2017 | Marshall Wace LLP | 0.56% | still open |
| February 9, 2017 | AQR Capital Management, LLC | 1.22% | still open |
| February 9, 2017 | Marshall Wace LLP | 0.56% | still open |
| February 8, 2017 | AQR Capital Management, LLC | 1.22% | still open |
| February 7, 2017 | Marshall Wace LLP | 0.66% | still open |
| February 6, 2017 | Marshall Wace LLP | 0.66% | still open |
| February 6, 2017 | Citadel Europe LLP | 0.60% | still open |
| February 5, 2017 | Citadel Europe LLP | 0.60% | still open |
| February 2, 2017 | Marshall Wace LLP | 0.76% | still open |
| February 1, 2017 | Marshall Wace LLP | 0.76% | still open |
| January 31, 2017 | GLG Partners LP | 0.67% | still open |
| January 30, 2017 | GLG Partners LP | 0.67% | still open |
| January 27, 2017 | Citadel Europe LLP | 0.50% | still open |
| January 26, 2017 | GLG Partners LP | 0.72% | still open |
| January 26, 2017 | Citadel Europe LLP | 0.50% | still open |
| January 25, 2017 | GLG Partners LP | 0.65% | still open |
| January 24, 2017 | Marshall Wace LLP | 0.80% | still open |
| January 24, 2017 | GLG Partners LP | 0.65% | still open |
| January 23, 2017 | Marshall Wace LLP | 0.80% | still open |
| January 19, 2017 | AQR Capital Management, LLC | 1.11% | still open |
| January 18, 2017 | AQR Capital Management, LLC | 1.11% | still open |
| January 13, 2017 | Citadel Europe LLP | 0.58% | still open |
| January 12, 2017 | BlackRock Investment Management (UK) Limited | 0.83% | still open |
| January 12, 2017 | Marshall Wace LLP | 0.72% | still open |
| January 12, 2017 | Citadel Europe LLP | 0.58% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Getinge AB, source Finansinspektionen, data as at February 2, 2022, https://www.quivad.com/action/getinge-ab?page=14